Effect of in vivo rapamycin treatment on de novo T-cell development in relation to induction of autoimmune-like immunopathology in the rat.

Cyclosporine (CsA) and FK506 are structurally unrelated immunosuppressants, but function in similar ways. FK506 and rapamycin (RAPA), on the other hand, have structural similarities, but act by different mechanisms to yield immunosuppression. Besides their immunosuppressive action, CsA and FK506 are known to interfere with T-cell development. CsA treatment after lethal X-irradiation and syngeneic bone marrow transplantation results in autoimmune disease, which is referred to as CsA-induced autoimmunity. In this study, we examined the effect of RAPA on T-cell development by flow cytometry and immunohistochemistry in female Lewis and Brown Norway rats. Irradiation and syngeneic bone marrow transplantation were performed before a 4-week course of RAPA administration to determine de novo T-cell development in relation to possible autoimmune phenomena. RAPA interfered with the maturation of thymocytes to the CD4+CD8+ DP stage, which resulted in a relative increase in TCRalphabeta(-) immature thymocytes, localized in a rim along the outer cortex. The thymus of RAPA-treated animals had a thinner cortex, leading to stronger thymic atrophy. In the periphery, only a few T cells were observed at the end of RAPA treatment. In the Lewis rat, a normal CD4/CD8 T-cell ratio and an increased Th1/Th2 ratio was observed within the T-cell population. Six weeks after cessation of RAPA therapy, the T-cell compartment was restored to normal, with respect to number and phenotype. In Brown Norway rats, however, T-cell areas were barely detectable at the end of RAPA treatment. The CD4/CD8 T-cell ratio was decreased as a result of a lower number of CD4 T cells; the Th1/Th2 ratio was increased but Th2 remained higher. Similar to Lewis rats, the situation was almost normalized 6 weeks after cessation of RAPA administration. However, Brown Norway rats, in contrast to Lewis rats, showed T-cell infiltration and concomitant induction of MHC class II in the submandibular salivary gland, as well as insulitis, in the pancreas. Possible relationships to Sjogren's disease and diabetes remain to be established.

[1]  J. Damoiseaux,et al.  Cutaneous immunopathology of cyclosporin-A-induced autoimmunity in the rat. , 1995, Clinical immunology and immunopathology.

[2]  J. Damoiseaux,et al.  Differential Effects of X-Irradiation and Cyclosporin-A Administration on the Thymus with Respect to the Generation of Cyclosporin-A-Induced Autoimmunity , 1995, Developmental immunology.

[3]  James M. Roberts,et al.  lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin , 1994, Nature.

[4]  V. Quesniaux,et al.  The Immunosuppressant Rapamycin Blocks In Vitro Responses to Hematopoietic Cytokines and Inhibits Recovering But Not Steady-State Hematopoiesis In Vivo , 1994 .

[5]  T. Hünig,et al.  Identification and characterization of rat gamma/delta T lymphocytes in peripheral lymphoid organs, small intestine, and skin with a monoclonal antibody to a constant determinant of the gamma/delta T cell receptor. , 1994, Journal of immunology.

[6]  Paul Tempst,et al.  RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs , 1994, Cell.

[7]  B. Huber,et al.  Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles. , 1994, Journal of immunology.

[8]  D. Pardoll,et al.  Cyclosporin A inhibits positive selection and delays negative selection in alpha beta TCR transgenic mice. , 1994, Journal of immunology.

[9]  Hongyu Luo,et al.  The effect of rapamycin on T cell development in mice , 1994, European journal of immunology.

[10]  D. Snover,et al.  Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome. , 1993, Journal of immunology.

[11]  G. Poschmann,et al.  Mercuric chloride-induced glomerulopathy in BN-rats: application to preclinical drug testing. , 1993, Transplantation proceedings.

[12]  P. Nieuwenhuis,et al.  Composition of rat CD4+ resting memory T-cell pool is influenced by major histocompatibility complex. , 1993, Transplantation proceedings.

[13]  K. Wodzig,et al.  Susceptibility and resistance to cyclosporin A-induced autoimmunity in rats. , 1993, Autoimmunity.

[14]  Marion H. Brown,et al.  Differential thymus dependence of rat CD8 isoform expression , 1992, European journal of immunology.

[15]  E. Bell,et al.  Functional maturation of recent thymic emigrants in the periphery: Development of alloreactivity correlates with the cyclic expression of CD45RC isoforms , 1992, European journal of immunology.

[16]  T. Tadakuma,et al.  Inhibition of programmed cell death by cyclosporin A; preferential blocking of cell death induced by signals via TCR/CD3 complex and its mode of action. , 1992, Immunology.

[17]  A. Thomson.  The spectrum of action of new immunosuppressive drugs , 1992, Clinical and experimental immunology.

[18]  G. Crabtree,et al.  Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.

[19]  R. Balderas,et al.  Vβ repertoire in rats and implications for endogenous superantigens , 1992 .

[20]  P. Nieuwenhuis,et al.  Post-thymic T cell development in rats: an update. , 1992, Biochemical Society transactions.

[21]  S. Schreiber,et al.  The mechanism of action of cyclosporin A and FK506. , 1992, Immunology today.

[22]  A. Thomson,et al.  Toxicity of rapamycin--a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat. , 1991, Transplantation.

[23]  M. Goldman,et al.  TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. , 1991, Immunology today.

[24]  R. Morris,et al.  Rapamycin: FK506's fraternal twin or distant cousin? , 1991, Immunology today.

[25]  K. Takai,et al.  Effects of FK506 on rat thymus: time‐course analysis by immunoperoxidase technique and flow cytofluorometry , 1990, Clinical and experimental immunology.

[26]  V. Křen,et al.  Lewis kidney grafts in RT4- and/or RT6-incompatible recipients. , 1990, Transplantation proceedings.

[27]  H. van Loveren,et al.  Cyclosporin and the rat thymus. An immunohistochemical study. , 1990, Thymus.

[28]  P. J. Van Breda Vriesman,et al.  Graft-versus-host disease: the need for a new terminology. , 1990, Immunology today.

[29]  M. Egerton,et al.  The generation and fate of thymocytes. , 1990, Seminars in immunology.

[30]  A. Kaplan,et al.  Induction of a syngeneic graft-versus-host disease-like syndrome in DBA/2 mice. , 1989, Transplantation.

[31]  H. Wallny,et al.  A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes , 1989, The Journal of experimental medicine.

[32]  J. Sprent,et al.  Abnormal differentiation of thymocytes in mice treated with cyclosporin A , 1988, Nature.

[33]  R. Schwartz,et al.  Effects of cyclosporine A on T cell development and clonal deletion. , 1988, Science.

[34]  E. Farmer,et al.  Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution , 1983, The Journal of experimental medicine.